Cargando…

Changes, limitations, and prospects of adult height in GH treatment for Japanese GHD patients

For the treatment of pituitary dwarfism (called pituitary short stature in 1987 and renamed as growth hormone deficiency [GHD] in 1993), pituitary-derived human growth hormone (phGH) was approved in 1975, and recombinant hGH (rhGH) was approved in 1988. Adult height in patients with isolated GH defi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Tanaka, Toshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society for Pediatric Endocrinology 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637418/ https://www.ncbi.nlm.nih.gov/pubmed/36405437 http://dx.doi.org/10.1297/cpe.2022-0034

Ejemplares similares

Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD
por: Blum, Werner F, et al.
Publicado: (2021)

SUN-260 The Severity of GH Deficiency (GHD) Does Not Affect Adherence to Treatment in GHD Prepubertal Children Taking rh-GH via the Easypod Device
por: Loche, Sandro, et al.
Publicado: (2019)

No Improvement of Adult Height in Non-growth Hormone (GH) Deficient Short Children with GH Treatment
por: Tanaka, Toshiaki, et al.
Publicado: (2006)

Diagnosis of Idiopathic GHD in Children Based on Response to rhGH Treatment: The Importance of GH Provocative Tests and IGF-1
por: Felício, João Soares, et al.
Publicado: (2019)

Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH
por: Miller, Bradley S, et al.
Publicado: (2023)

History of GH treatment in Japan
por: Tanaka, Toshiaki
Publicado: (2021)

The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis
por: Verhelst, Johan, et al.
Publicado: (2018)

Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3
por: Sävendahl, Lars, et al.
Publicado: (2021)

Correction to: “Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH”
Publicado: (2023)

Discrepancies between Physician and Parent Perceptions of Psychosocial Problems of GHD Children Undergoing GH Therapy in Japan
por: Arisaka, Osamu, et al.
Publicado: (2006)

Evaluation of Permanent Growth Hormone Deficiency (GHD) in Young Adults with Childhood Onset GHD: A multicenter study
por: Berberoğlu, Merih, et al.
Publicado: (2008)

Effects of recombinant growth hormone (GH) replacement and psychomotor and cognitive stimulation in the neurodevelopment of GH-deficient (GHD) children with cerebral palsy: a pilot study
por: Devesa, Jesús, et al.
Publicado: (2011)

Effects of Growth Hormone (GH) Supplementation on Dermatoscopic Evolution of Pigmentary Lesions in Children with Growth Hormone Deficiency (GHD)
por: Panarese, Fabrizio, et al.
Publicado: (2022)

The Growth Hormone Deficiency (GHD) Reversal Trial: effect on final height of discontinuation versus continuation of growth hormone treatment in pubertal children with isolated GHD—a non-inferiority Randomised Controlled Trial (RCT)
por: Brettell, Elizabeth, et al.
Publicado: (2023)

Ghd8 controls rice photoperiod sensitivity by forming a complex that interacts with Ghd7
por: Wang, Peng, et al.
Publicado: (2019)

Favorable Impacts of Growth Hormone (GH) Replacement Therapy on Atherogenic Risks in Japanese Children with GH Deficiency
por: Kohno, Hitoshi, et al.
Publicado: (2012)

GH Responsiveness Is not Correlated to IGF1 P2 Promoter Methylation in Children With Turner Syndrome, GHD and SGA Short Stature
por: Apel, Anja, et al.
Publicado: (2022)

Comparative Sequence Analysis of the Ghd7 Orthologous Regions Revealed Movement of Ghd7 in the Grass Genomes
por: Yang, Lu, et al.
Publicado: (2012)

Target Height and Target Range for Japanese Children: Revisited
por: Ogata, Tsutomu, et al.
Publicado: (2007)

SUN-244 Birth and Perinatal Characteristics of Children with Congenital GH Deficiency (GHD) Due to Abnormal Pituitary Development: Data from a Prospective, Multinational Observational Study
por: Child, Christopher, et al.
Publicado: (2019)

Corrigendum: GH responsiveness is not correlated to IGF1 P2 promoter methylation in children with Turner syndrome, GHD and SGA short stature
por: Apel, Anja, et al.
Publicado: (2022)

Onset of puberty and near adult height in short children born small for gestational age and treated with GH: Interim analysis of up to 10 years of treatment in Japan
por: Tanaka, Toshiaki, et al.
Publicado: (2015)

Onset of puberty and near adult height in short children born small for gestational age and treated with GH: Interim analysis of up to 10 years of treatment in Japan
por: Tanaka, Toshiaki, et al.
Publicado: (2015)

Psychometric Validation of the Growth Hormone Deficiency–Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency–Parent Treatment Burden Measure (GHD-PTB)
por: Brod, Meryl, et al.
Publicado: (2022)

Deriving reference values and utilities for the QoL-AGHDA in adult GHD
por: Busschbach, J. J. V., et al.
Publicado: (2010)

Third-generation Aromatase Inhibitor Improved Adult Height in a Japanese Boy with Testotoxicosis
por: Yoshizawa-Ogasawara, Atsuko, et al.
Publicado: (2014)

Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study
por: Blankenstein, Oliver, et al.
Publicado: (2017)

Evolution and Association Analysis of Ghd7 in Rice
por: Lu, Li, et al.
Publicado: (2012)

Stearoyl-ACP Δ(9) Desaturase 6 and 8 (GhA-SAD6 and GhD-SAD8) Are Responsible for Biosynthesis of Palmitoleic Acid Specifically in Developing Endosperm of Upland Cotton Seeds
por: Liu, Baoling, et al.
Publicado: (2019)

Combined Treatment with Gonadotropin-releasing Hormone Analog and Anabolic Steroid Hormone Increased Pubertal Height Gain and Adult Height in Boys with Early Puberty for Height
por: Tanaka, Toshiaki, et al.
Publicado: (2012)

Increased Secretion of Endogenous GH after Treatment with an Intranasal GH-releasing Peptide-2 Spray Does Not Promote Growth in Short Children with GH Deficiency
por: Tanaka, Toshiaki, et al.
Publicado: (2014)

Genetic Interactions Among Ghd7, Ghd8, OsPRR37 and Hd1 Contribute to Large Variation in Heading Date in Rice
por: Zhang, Bo, et al.
Publicado: (2019)

SUN-250 Natural History of Growth in Patients with SHOX Gene Haploinsufficiency and Impact of Treatment with rhGH in Adult Height
por: Menezes De Andrade, Nathalia, et al.
Publicado: (2019)

Evolving pituitary hormone deficits in primarily isolated GHD: a review and experts’ consensus
por: Binder, Gerhard, et al.
Publicado: (2020)

Metabolomics as a potential tool for the diagnosis of growth hormone deficiency (GHD): a review
por: San-Martin, Breno Sena De, et al.
Publicado: (2020)

Assessing the Impact of Growth Hormone Deficiency (GHD) in Adults: Interpreting Change of the Treatment-Related Impact Measure—Adult Growth Hormone Deficiency (TRIM-AGHD)
por: Brod, Meryl, et al.
Publicado: (2018)

Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients
por: Hartman, Mark L., et al.
Publicado: (2013)

The limits of normal approximation for adult height
por: Slavskii, Sergei A., et al.
Publicado: (2021)

SAT-091 First Report of Disease-Specific Patient-Reported Outcomes from a Randomized Phase 2 Trial of Once-Weekly Somapacitan vs Daily GH in Children with GHD
por: Brod, Meryl, et al.
Publicado: (2020)

Effects of Growth Hormone (GH) Therapy Withdrawal on Glucose Metabolism in Not Confirmed GH Deficient Adolescents at Final Height
por: Prodam, Flavia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tiupor685vf8hkra2eff6n6hvo